Cargando…
Non-invasive dye dilution method for measuring an atrial septal defect shunt size
AIMS: Objective of this study was to evaluate the feasibility of the non-invasive dye dilution method to quantify shunt size related to atrial septal defects (ASD). The diagnostic accuracy of shunt size determination in ASD’s has been suboptimal with common non-invasive methods. We have previously d...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537437/ https://www.ncbi.nlm.nih.gov/pubmed/33020256 http://dx.doi.org/10.1136/openhrt-2020-001313 |
_version_ | 1783590673460494336 |
---|---|
author | Muroke, Valtteri Jalanko, Mikko Simonen, Piia Holmström, Miia Ventilä, Markku Sinisalo, Juha |
author_facet | Muroke, Valtteri Jalanko, Mikko Simonen, Piia Holmström, Miia Ventilä, Markku Sinisalo, Juha |
author_sort | Muroke, Valtteri |
collection | PubMed |
description | AIMS: Objective of this study was to evaluate the feasibility of the non-invasive dye dilution method to quantify shunt size related to atrial septal defects (ASD). The diagnostic accuracy of shunt size determination in ASD’s has been suboptimal with common non-invasive methods. We have previously developed a cost-effective and time-effective non-invasive dye dilution method. In this method, the indocyanine green solution is injected into the antecubital vein and the appearance of the dye is detected with an earpiece densitometer. METHODS AND RESULTS: We studied 192 patients with an ASD. Mean pulmonary blood flow/systemic blood flow (Qp/Qs) was measured with dye dilution technique and compared with following methods: Fick’s invasive oximetry (n=49), transoesophageal echocardiography (TEE) measuring ASD size (n=143) and cardiac MR (CMR) (n=9). For the first 49 patients, Qp/Qs was 2.05±0.70 with the Fick’s invasive oximetry and 2.12±0.68 with dye dilution method with an excellent correlation between the two methods (R=0.902, p<0.001). In the second study sample, the ASD size by TEE was 15±6 mm on average, and the mean Qp/Qs 2.16±0.65 measured with dye dilution method with a good correlation between the methods (R=0.674, p<0.001). Qp/Qs measured with CMR was 1.87±0.40 resulting in a good correlation with the dye dilution method (R=0.696, p=0.037). CONCLUSION: The dye dilution method with earpiece densitometer recording is a clinically feasible and reliable method to assess shunt size in ASDs. |
format | Online Article Text |
id | pubmed-7537437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-75374372020-10-07 Non-invasive dye dilution method for measuring an atrial septal defect shunt size Muroke, Valtteri Jalanko, Mikko Simonen, Piia Holmström, Miia Ventilä, Markku Sinisalo, Juha Open Heart Congenital Heart Disease AIMS: Objective of this study was to evaluate the feasibility of the non-invasive dye dilution method to quantify shunt size related to atrial septal defects (ASD). The diagnostic accuracy of shunt size determination in ASD’s has been suboptimal with common non-invasive methods. We have previously developed a cost-effective and time-effective non-invasive dye dilution method. In this method, the indocyanine green solution is injected into the antecubital vein and the appearance of the dye is detected with an earpiece densitometer. METHODS AND RESULTS: We studied 192 patients with an ASD. Mean pulmonary blood flow/systemic blood flow (Qp/Qs) was measured with dye dilution technique and compared with following methods: Fick’s invasive oximetry (n=49), transoesophageal echocardiography (TEE) measuring ASD size (n=143) and cardiac MR (CMR) (n=9). For the first 49 patients, Qp/Qs was 2.05±0.70 with the Fick’s invasive oximetry and 2.12±0.68 with dye dilution method with an excellent correlation between the two methods (R=0.902, p<0.001). In the second study sample, the ASD size by TEE was 15±6 mm on average, and the mean Qp/Qs 2.16±0.65 measured with dye dilution method with a good correlation between the methods (R=0.674, p<0.001). Qp/Qs measured with CMR was 1.87±0.40 resulting in a good correlation with the dye dilution method (R=0.696, p=0.037). CONCLUSION: The dye dilution method with earpiece densitometer recording is a clinically feasible and reliable method to assess shunt size in ASDs. BMJ Publishing Group 2020-10-05 /pmc/articles/PMC7537437/ /pubmed/33020256 http://dx.doi.org/10.1136/openhrt-2020-001313 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Congenital Heart Disease Muroke, Valtteri Jalanko, Mikko Simonen, Piia Holmström, Miia Ventilä, Markku Sinisalo, Juha Non-invasive dye dilution method for measuring an atrial septal defect shunt size |
title | Non-invasive dye dilution method for measuring an atrial septal defect shunt size |
title_full | Non-invasive dye dilution method for measuring an atrial septal defect shunt size |
title_fullStr | Non-invasive dye dilution method for measuring an atrial septal defect shunt size |
title_full_unstemmed | Non-invasive dye dilution method for measuring an atrial septal defect shunt size |
title_short | Non-invasive dye dilution method for measuring an atrial septal defect shunt size |
title_sort | non-invasive dye dilution method for measuring an atrial septal defect shunt size |
topic | Congenital Heart Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537437/ https://www.ncbi.nlm.nih.gov/pubmed/33020256 http://dx.doi.org/10.1136/openhrt-2020-001313 |
work_keys_str_mv | AT murokevaltteri noninvasivedyedilutionmethodformeasuringanatrialseptaldefectshuntsize AT jalankomikko noninvasivedyedilutionmethodformeasuringanatrialseptaldefectshuntsize AT simonenpiia noninvasivedyedilutionmethodformeasuringanatrialseptaldefectshuntsize AT holmstrommiia noninvasivedyedilutionmethodformeasuringanatrialseptaldefectshuntsize AT ventilamarkku noninvasivedyedilutionmethodformeasuringanatrialseptaldefectshuntsize AT sinisalojuha noninvasivedyedilutionmethodformeasuringanatrialseptaldefectshuntsize |